Effect of change in vascular access on patient mortality in hemodialysis patients.

BACKGROUND Hemodialysis patients using a catheter have a greater mortality risk than those using an arteriovenous (AV) access (fistula or graft). However, catheter-dependent patients also differ from those with an AV access in several clinical features, and these differences may themselves contribute to their excess mortality. METHODS The current study evaluates whether a change in vascular access affects risk for mortality in patients enrolled in the Hemodialysis Study. Time-dependent Cox regression was used to relate mortality risk to current type of access and change in access type during the preceding 1 year. RESULTS Compared with patients who dialyzed using an AV access at both the beginning and end of the preceding 1-year interval, relative risks for mortality were 3.43 (95% confidence interval [CI], 2.42 to 4.86) in patients who dialyzed with a catheter at both times; 2.38 (95% CI, 1.76 to 3.23) in patients switching from an AV access to a catheter, and 1.37 (95% CI, 0.81 to 2.32) in patients switching from a catheter to an AV access. Change from AV access to a catheter was associated with an antecedent decrease in serum albumin level (odds ratio, 1.25; 95% CI, 1.09 to 1.45 per 0.5 g/dL; P = 0.002), weight loss (odds ratio, 1.14; 95% CI, 1.06 to 1.22 per 2 kg; P < 0.001), and decreases in equilibrated normalized protein catabolic rate (odds ratio, 2.22; 95% CI, 1.41 to 3.57 per 0.25 g/kg/d; P < 0.001) and non-access-related hospitalization (odds ratio, 1.19; 95% CI, 1.06 to 1.32 per 1 additional hospitalization over 4 months; P = 0.002). Change from a catheter to AV access was predicted by only the antecedent non-access-related hospitalization rate (odds ratio, 0.93; 95% CI, 0.87 to 0.97 per 1 additional hospitalization over 4 months; P < 0.001). CONCLUSION Change from a catheter to AV access is associated with a substantial decrease in mortality risk.

[1]  A. Asif,et al.  Conversion of tunneled hemodialysis catheter-consigned patients to arteriovenous fistula. , 2005, Kidney international.

[2]  M. Allon Dialysis catheter-related bacteremia: treatment and prophylaxis. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[3]  G. Beck,et al.  Dialysis dose and the effect of gender and body size on outcome in the HEMO Study. , 2004, Kidney international.

[4]  R. Atkins,et al.  Vascular access and all-cause mortality: a propensity score analysis. , 2004, Journal of the American Society of Nephrology : JASN.

[5]  A. Collins,et al.  The association of initial hemodialysis access type with mortality outcomes in elderly Medicare ESRD patients. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[6]  G. Beathard,et al.  Aggressive treatment of early fistula failure. , 2003, Kidney international.

[7]  S. Beddhu,et al.  Impact of dialysis dose and membrane on infection-related hospitalization and death: results of the HEMO Study. , 2003, Journal of the American Society of Nephrology : JASN.

[8]  Eduardo Lacson,et al.  The effects of higher hemoglobin levels on mortality and hospitalization in hemodialysis patients. , 2003, Kidney international.

[9]  B. Gillespie,et al.  Creation, cannulation and survival of arteriovenous fistulae: data from the Dialysis Outcomes and Practice Patterns Study. , 2003, Kidney international.

[10]  M. Robbin,et al.  Gender differences in outcomes of arteriovenous fistulas in hemodialysis patients. , 2003, Kidney international.

[11]  Johanna T Dwyer,et al.  Effect of dialysis dose and membrane flux in maintenance hemodialysis. , 2002, The New England journal of medicine.

[12]  F. Port,et al.  Mortality risk in hemodialysis patients and changes in nutritional indicators: DOPPS. , 2002, Kidney international.

[13]  M. Robbin,et al.  Increasing arteriovenous fistulas in hemodialysis patients: problems and solutions. , 2002, Kidney international.

[14]  W. McClellan,et al.  Vascular access and increased risk of death among hemodialysis patients. , 2002, Kidney international.

[15]  K. Stevenson,et al.  Epidemiology of hemodialysis vascular access infections from longitudinal infection surveillance data: predicting the impact of NKF-DOQI clinical practice guidelines for vascular access. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[16]  R. Wolfe,et al.  Vascular access use in Europe and the United States: results from the DOPPS. , 2002, Kidney international.

[17]  L. Turmel-Rodrigues,et al.  Salvage of immature forearm fistulas for haemodialysis by interventional radiology. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[18]  E W Young,et al.  Type of vascular access and mortality in U.S. hemodialysis patients. , 2001, Kidney international.

[19]  J. Kusek,et al.  Comorbidity assessment using the Index of Coexistent Diseases in a multicenter clinical trial. , 2001, Kidney international.

[20]  J. Walls,et al.  End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link? , 2001, Kidney international.

[21]  C. Schmid,et al.  Comorbidity Assessment in Hemodialysis and Peritoneal Dialysis Using the Index of Coexistent Disease , 2000, Seminars in dialysis.

[22]  J. Bower,et al.  Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients. , 1999, Kidney international.

[23]  W. McClellan,et al.  Mortality in end-stage renal disease is associated with facility-to-facility differences in adequacy of hemodialysis. , 1998, Journal of the American Society of Nephrology : JASN.

[24]  B. Hoen,et al.  EPIBACDIAL: a multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients. , 1998, Journal of the American Society of Nephrology : JASN.

[25]  F. Port,et al.  Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[26]  E G Lowrie,et al.  The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. , 1993, The New England journal of medicine.

[27]  P. Watson,et al.  Total body water volumes for adult males and females estimated from simple anthropometric measurements. , 1980, The American journal of clinical nutrition.